HUMASIS strives to develop, manufacture, and market IVD for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine in rapid tests for home and laboratory use. New quantitative POCTs including h-FABP, D-dimer, hs-CRP, G6PD, and Vitamin-D are regularly introduced to cover the constantly expanding range of applications. HUMASIS has reached more than 45 countries worldwide and mainly targeting the US market to become a global company.